Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Robins

Showing results (141-150 of 221) with videos related to

Pageof 23
Sort By:
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugatesL G Durrant, R A Robins, R A Marksman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucinM R Price, M Sekowski, G Y Yang, et al.
The Science of the Total Environment|October 27, 2004
Sustainable development of urban transport systems and human exposure to air pollutionR N Colvile, S Kaur, R Britter, et al.
Transplantation Proceedings|April 1, 1996
Analysis of alpha 1,3-galactosyltransferase knockout miceM Tange, R Tearle, M Katerelos, et al.
European Journal of Immunology|January 1, 1980
Studies on the immunobiology of rnu/rnu "nude" rats with congenital aplasia of the thymusC G Brooks, P J Webb, R A Robins, et al.
British Medical Journal|July 23, 1977
Circulating immune complexes in patients with breast cancerK Hoffken, I D Meredith, R A Robins, et al.
Lancet (London, England)|March 25, 1978
Immune complexes and prognosis of human breast cancerK Höffken, I D Meredith, R A Robins, et al.
Histopathology|May 1, 1984
A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterizationI O Ellis, R A Robins, C W Elston, et al.
Archives of Gynecology|January 1, 1980
Tumour markers with unknown functions in gynaecological neoplasiaM R Price, P J McLaughlin, R A Robins, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.
Pageof 23

Showing results (141-150 of 221) with videos related to

Sort By:
Pageof 23
Cancer Immunology, Immunotherapy : CII|January 1, 1989
Abrogation of antibody responses in rats to murine monoclonal antibody 791T/36 by treatment with daunomycin-cis-aconityl-791T/36 conjugatesL G Durrant, R A Robins, R A Marksman, et al.
Cancer Immunology, Immunotherapy : CII|January 1, 1991
Reactivity of an anti-(human gastric carcinoma) monoclonal antibody with core-related peptides of gastrointestinal mucinM R Price, M Sekowski, G Y Yang, et al.
The Science of the Total Environment|October 27, 2004
Sustainable development of urban transport systems and human exposure to air pollutionR N Colvile, S Kaur, R Britter, et al.
Transplantation Proceedings|April 1, 1996
Analysis of alpha 1,3-galactosyltransferase knockout miceM Tange, R Tearle, M Katerelos, et al.
European Journal of Immunology|January 1, 1980
Studies on the immunobiology of rnu/rnu "nude" rats with congenital aplasia of the thymusC G Brooks, P J Webb, R A Robins, et al.
British Medical Journal|July 23, 1977
Circulating immune complexes in patients with breast cancerK Hoffken, I D Meredith, R A Robins, et al.
Lancet (London, England)|March 25, 1978
Immune complexes and prognosis of human breast cancerK Höffken, I D Meredith, R A Robins, et al.
Histopathology|May 1, 1984
A monoclonal antibody, NCRC-11, raised to human breast carcinoma. 1. Production and immunohistological characterizationI O Ellis, R A Robins, C W Elston, et al.
Archives of Gynecology|January 1, 1980
Tumour markers with unknown functions in gynaecological neoplasiaM R Price, P J McLaughlin, R A Robins, et al.
Cancer Immunology, Immunotherapy : CII|June 18, 2003
Enhanced expression of the complement regulatory protein CD55 predicts a poor prognosis in colorectal cancer patientsL G Durrant, M A Chapman, D J Buckley, et al.
Pageof 23